130 related articles for article (PubMed ID: 38035312)
1. Impact of Ambulatory Care Pharmacist-Led Management on Hemoglobin A1c Values among Patients with Uncontrolled Diabetes in a Primary Care Clinic vs Usual Care over Two Years.
Mohammad I; Poyer A; Hamoud R; George J
Innov Pharm; 2023; 14(1):. PubMed ID: 38035312
[No Abstract] [Full Text] [Related]
2. Impact of Ambulatory Care Pharmacist-Led Diabetes Mellitus Management on Hemoglobin A1c Values Among Patients With Diabetes in a Primary Care Clinic Over Two Years.
Mohammad I; George J; Zimmerman J; Elteriefi R
Innov Pharm; 2022; 13(2):. PubMed ID: 36654698
[No Abstract] [Full Text] [Related]
3. Impact of clinical pharmacist-led diabetes management clinic on health outcomes at an academic hospital in Riyadh, Saudi Arabia: A prospective cohort study.
Alsuwayni B; Alhossan A
Saudi Pharm J; 2020 Dec; 28(12):1756-1759. PubMed ID: 33424266
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
[TBL] [Abstract][Full Text] [Related]
5. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
Chung N; Rascati K; Lopez D; Jokerst J; Garza A
J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
[TBL] [Abstract][Full Text] [Related]
6. A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.
Fink RM; Mooney EV; Saseen JJ; Billups SJ
Pharm Pract (Granada); 2019; 17(4):1618. PubMed ID: 31897259
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
Padiyara RS; D'Souza JJ; Rihani RS
J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System.
Hui RL; Chang CC; Niu F; Tang YK; Harano D; Deguzman L; Kao DJ; Awsare S; Draves M
J Manag Care Spec Pharm; 2019 Aug; 25(8):927-934. PubMed ID: 31347983
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
Korcegez EI; Sancar M; Demirkan K
J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist Intervention Lowers HgbA1c in Diabetic Patients Regardless of HIV Status.
Nelson NE; Wilson M; Fine J; Hluhanich RM
J Pharm Pract Res; 2021 Aug; 51(4):307-313. PubMed ID: 34539238
[TBL] [Abstract][Full Text] [Related]
12. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Diabetes Mellitus Type 2 Control in Home-Based Primary Care Patients Managed by Clinical Pharmacy Specialists.
Starikova S; Castelvecchi A; Corboy A
Sr Care Pharm; 2022 Aug; 37(8):366-373. PubMed ID: 35879848
[No Abstract] [Full Text] [Related]
14. The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home.
Prudencio J; Cutler T; Roberts S; Marin S; Wilson M
J Manag Care Spec Pharm; 2018 May; 24(5):423-429. PubMed ID: 29694290
[TBL] [Abstract][Full Text] [Related]
15. Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD.
Aspinall SL; Cunningham FE; Zhao X; Boresi JS; Tonnu-Mihara IQ; Smith KJ; Stone RA; Good CB;
Am J Kidney Dis; 2012 Sep; 60(3):371-9. PubMed ID: 22633556
[TBL] [Abstract][Full Text] [Related]
16. Effect of Clinical Pharmacist Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes in a Rural Setting.
Sullivan J; Jett BP; Cradick M; Zuber J
Ann Pharmacother; 2016 Dec; 50(12):1023-1027. PubMed ID: 27497068
[TBL] [Abstract][Full Text] [Related]
17. Assessing the Effect of Pharmacist Care on Diabetes-Related Outcomes in a Rural Outpatient Clinic: A Retrospective Case-Control Study.
Moreau C; Sando KR; Zambrano DH
Ann Pharmacother; 2017 Jun; 51(6):473-478. PubMed ID: 28064508
[TBL] [Abstract][Full Text] [Related]
18. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers.
Mazzolini TA; Irons BK; Schell EC; Seifert CF
J Manag Care Pharm; 2005; 11(9):763-71. PubMed ID: 16300420
[TBL] [Abstract][Full Text] [Related]
19. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility.
Wallgren S; Berry-Cabán CS; Bowers L
Ann Pharmacother; 2012 Mar; 46(3):353-7. PubMed ID: 22395249
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
